4 Biotechs' Dominant Moves

In this video, Motley Fool health care analyst David Williamson gives us the story behind two big biotech jumps today and two big stumbles. Sequenom (Nasdaq: SQNM  ) continues its rally from Friday with more good news that its RetnaGene AMD accurately predicts the progression of wet age-related macular degeneration; this has shares up an additional 8% on top of Friday's 19%. Repros Therapeutics (Nasdaq: RPRX  ) also up today ahead of presenting both of its phase 2 drugs, Androxal and Proellex, at the Lazard conference tomorrow. Meanwhile, Cyclacel (Nasdaq: CYCC  ) and Transcept (Nasdaq: TSPT  ) are both down today after disappointing earnings releases.

While you can certainly make huge gains in biotech and pharmaceuticals when these stocks make big jumps, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2110480, ~/Articles/ArticleHandler.aspx, 7/26/2014 9:27:01 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement